GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report

November 2020 | 45 pages | ID: G2C83469870EN
MarketLine

Abstracts

GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report

Summary

GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

GlaxoSmithKline Consumer Healthcare Ltd (GSKCH), a subsidiary of GlaxoSmithKline plc is a manufacturer and marketer of health food drinks. The company's product portfolio comprise of health drinks, oats, biscuits, calcium supplement, noodles, digestive health products, pain relief balms and drugs, cold and flu drugs and nasal decongestant, toothpaste and tooth brush, prescribed medicines and vaccines. GSKCH offers its products under the brand names Horlicks, Boost, Ostocalcium, Viva, Maltova, Eno, Crocin, Iodex, Otrivin and Sensodyne. The company sells its products through marketing and distribution network such as distributors, retail outlets and sub distributors. It operates manufacturing facilities in Nabha, Sonepat and Rajahmundry in India. GSKCH is headquartered in Gurgaon, Haryana, India.

Scope

• Detailed information on GlaxoSmithkline Consumer Healthcare Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting GlaxoSmithkline Consumer Healthcare Ltd in the form of a SWOT analysis
• An in-depth view of the business model of GlaxoSmithkline Consumer Healthcare Ltd including a breakdown and examination of key business segments
• Intelligence on GlaxoSmithkline Consumer Healthcare Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about GlaxoSmithkline Consumer Healthcare Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of GlaxoSmithkline Consumer Healthcare Ltd and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess GlaxoSmithkline Consumer Healthcare Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on GlaxoSmithkline Consumer Healthcare Ltd's business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
GlaxoSmithkline Consumer Healthcare Ltd: Company Overview
GlaxoSmithkline Consumer Healthcare Ltd: Overview and Key Facts
GlaxoSmithkline Consumer Healthcare Ltd: Overview
GlaxoSmithkline Consumer Healthcare Ltd: Key Facts
GlaxoSmithkline Consumer Healthcare Ltd: Key Employees
GlaxoSmithkline Consumer Healthcare Ltd: Key Employee Biographies
GlaxoSmithkline Consumer Healthcare Ltd: Major Products and Services
GlaxoSmithkline Consumer Healthcare Ltd: Company History
GlaxoSmithkline Consumer Healthcare Ltd: Management Statement
GlaxoSmithkline Consumer Healthcare Ltd: Locations and Subsidiaries
GlaxoSmithkline Consumer Healthcare Ltd: Key Competitors
GlaxoSmithkline Consumer Healthcare Ltd: Company Analysis
GlaxoSmithkline Consumer Healthcare Ltd: Business Description
GlaxoSmithkline Consumer Healthcare Ltd: SWOT Analysis
GlaxoSmithkline Consumer Healthcare Ltd: SWOT Overview
GlaxoSmithkline Consumer Healthcare Ltd: Strengths
GlaxoSmithkline Consumer Healthcare Ltd: Weaknesses
GlaxoSmithkline Consumer Healthcare Ltd: Opportunities
GlaxoSmithkline Consumer Healthcare Ltd: Threats
GlaxoSmithkline Consumer Healthcare Ltd: Corporate Financial Deals Activity
GlaxoSmithkline Consumer Healthcare Ltd: Financial Deals Overview
GlaxoSmithkline Consumer Healthcare Ltd: Targets and Partners
GlaxoSmithkline Consumer Healthcare Ltd: Top Deals 2016 - 2020YTD*
GlaxoSmithkline Consumer Healthcare Ltd: Advisors
GlaxoSmithkline Consumer Healthcare Ltd: Top Legal Advisors
GlaxoSmithkline Consumer Healthcare Ltd: Top Financial Advisors
GlaxoSmithkline Consumer Healthcare Ltd: Mergers and Acquisitions
GlaxoSmithkline Consumer Healthcare Ltd: Partnership
GlaxoSmithkline Consumer Healthcare Ltd: Divestments
GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership
GlaxoSmithkline Consumer Healthcare Ltd: Recent Developments
GlaxoSmithkline Consumer Healthcare Ltd: News and Events Summary
GlaxoSmithkline Consumer Healthcare Ltd: Business Expansion
GlaxoSmithkline Consumer Healthcare Ltd: Contracts
GlaxoSmithkline Consumer Healthcare Ltd: Financial Deals
GlaxoSmithkline Consumer Healthcare Ltd: Financial Performance
GlaxoSmithkline Consumer Healthcare Ltd: Market Developments
GlaxoSmithkline Consumer Healthcare Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: GlaxoSmithkline Consumer Healthcare Ltd: Key Facts
Table 2: GlaxoSmithkline Consumer Healthcare Ltd: Key Employees
Table 3: GlaxoSmithkline Consumer Healthcare Ltd: Company History
Table 4: GlaxoSmithkline Consumer Healthcare Ltd: Locations and Subsidiaries
Table 5: GlaxoSmithkline Consumer Healthcare Ltd: Key Competitors
Table 6: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: GlaxoSmithkline Consumer Healthcare Ltd: M&A Activity by Geography (TTM*)
Table 8: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: GlaxoSmithkline Consumer Healthcare Ltd: M&A Average Deal Size - Value (US$m)
Table 10: GlaxoSmithkline Consumer Healthcare Ltd: Targets and Partners
Table 11: GlaxoSmithkline Consumer Healthcare Ltd: Top Deals 2016 - 2020YTD*
Table 12: GlaxoSmithkline Consumer Healthcare Ltd: Legal Advisor Ranking by Value (US$m)
Table 13: GlaxoSmithkline Consumer Healthcare Ltd: Financial Advisor Ranking by Value (US$m)
Table 14: GlaxoSmithkline Consumer Healthcare Ltd: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 16: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 17: GlaxoSmithkline Consumer Healthcare Ltd: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 18: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 19: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 20: GlaxoSmithkline Consumer Healthcare Ltd: News and Events Summary
Table 21: GlaxoSmithkline Consumer Healthcare Ltd: Business Expansion
Table 22: GlaxoSmithkline Consumer Healthcare Ltd: Contracts
Table 23: GlaxoSmithkline Consumer Healthcare Ltd: Financial Deals
Table 24: GlaxoSmithkline Consumer Healthcare Ltd: Financial Performance
Table 25: GlaxoSmithkline Consumer Healthcare Ltd: Market Developments
Table 26: GlaxoSmithkline Consumer Healthcare Ltd: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GlaxoSmithkline Consumer Healthcare Ltd: M&A Activity by Geography (TTM*)
Figure 3: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Figure 4: GlaxoSmithkline Consumer Healthcare Ltd: M&A Average Deal Size - Value (US$m)
Figure 5: GlaxoSmithkline Consumer Healthcare Ltd: M&A Volume and Value Trend (2016 - YTD*2020)
Figure 6: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Volume and Value Trend (2016 - YTD*2020)
Figure 7: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Trend by Deal Type (2016 - YTD*2020)
Figure 8: GlaxoSmithkline Consumer Healthcare Ltd: Divestments Volume and Value Trend (2016 - YTD*2020)
Figure 9: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Figure 10: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)